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Introduction: If we could prove the diagnostic accuracy of hepatic vein resistive index in detecting liver fibrosis in 
chronic liver disease patients, this would be beneficial for the patients as it is a non-invasive, readily available, 
and cost-effective technique for the diagnosis of liver fibrosis. This will help the physicians in the early initiation 
of definitive management. 
Materials and Methods: Seventy-five (n=75) patients with hepatitis B aged between 18-50 years were enrolled. 
Hepatic vein resistive index and liver biopsy were performed in even-patients. Sensitivity, Specificity, PPV, NPV, 
and overall accuracy of the hepatic vein resistive index was calculated. 
Results: Average age group studied was 38y ± 8.2 SD. 57.3 % (N=43) were males and 42.7% (n=32) patients were 
females respectively. Data of this work Exhibits various statistical indicators 77%. 96.7%. 97.2%. 74.3% and 85.3% 
respectively.  
Conclusion: Hepatic vein resistive index measured by ultrasonography can detect liver fibrosis in CLD with 
overall sensitivity, Specificity, PPV, NPV, and accuracy of 77.7%. 96.7%. 97.2%. 74.3% and 85.3% respectively. 
Keywords: Diagnostic accuracy, chronic liver disease, hepatic vein resistive index, hepatic fibrosis. 




Chronic liver disease is a progressive condition that 
leads eventually to liver fibrosis and liver failure.1-2 
Hepatobiliary disorders are commonly seen in clinical 
practice nowadays among which patients with 
hepatitis B and C arc most commonly encountered.3-4 
Hepatic fibrosis is characterized by the formation of 
hepatic scars which leads to cirrhosis.5 Chronic liver 
disease has many causative etiologies including viral 
infections, alcohol overdose, steatotic liver disease, 
primary sclerosing cholangitis, autoimmune disease, 
and hemochromatosis.6-8 The incidence of hepatitis B 
infection depends upon geographical location and is 
increasing annually ranging between 3% and 9%.9 The 
predictors of rising mortality in hepatitis B virus-
associated mortality patterns are age over 45 years at 
the time of diagnosis, male sex, and history of 
alcoholism and nosocomial risk factors.10-11 The overall 
burden of Hepatitis B Virus infection is being 
recognized increasingly.12-13 As liver cirrhosis 
progresses, there is an alteration in the liver 
parenchyma, and this fibrosis also affects the walls of 
hepatic veins which increases resistance in the hepatic 
veins thus leading to an increase in the resistive index 
on color Doppler examination which helps detect stage 
fibrosis/cirrhosis.14-17 Hepatic venous Doppler is a 
readily available, cheap, simple, and non-invasive 
procedure. 
Local studies are deficient in cirrhosis determined by 
HVRI compared with liver biopsy.18 Depending upon 
the results of this study, the Hepatic vein resistive 
index by Doppler ultrasound can reliably be applied to 
avoid undue liver biopsies. 
 
Materials and Methods 
 
Study Objective: To determine the diagnostic 
accuracy of hepatic vein resistive index in the 
detection of hepatic fibrosis in patients of chronic liver 
disease keeping liver biopsy (histopathology) as the 
gold standard. 
Study Design: Cross-sectional validation study. 
Settings: The study was done in the Radiology 
Department, RMC, and Allied Hospitals, Rawalpindi, 
in association with the Pathology department. 
Duration: Six months (22-09-2015 to 21-03-2016). 
Sample Size: The study included 75 patients. 




a) Inclusion Criteria: 
1) Positive PCR of the hepatitis B virus. 
     PCR measured by quantitative method; 
 Patients with e antigen-positive 
having a viral load of 20,000 IU/ml. 
 Patients with e antigen-negative 
having a viral load of 2000 IU/ml. 
2) Age between 18 years and 50 years (both gender). 
b) Exclusion Criteria: 
1) Patients having splenomegaly. 
2) Patients who are on interferon therapy. 
3) Patients having esophageal varices. 
Data collection procedure: After approval by the 
ethical committee of Rawalpindi medical college and 
Allied hospitals, patients fulfilling the inclusion 
criteria were subjected to Doppler ultrasound of 
hepatic vein. Informed consent was obtained from all 
the patients and the procedure was explained to all 
patients. The procedure was carried out with a pulsed 
Doppler flowmeter by using a 5MHz convex 
curvilinear transducer.  
Hepatic vein resistive index is calculated by using the 
formula “maximum negative velocity minus minimum 
negative velocity (or positive velocity in case of a 
triphasic flow signal)/maximum negative velocity”. 
HVRI=maximum negative velocity-minimum negative 
velocity  
Maximum negative velocity 
F0=1.45 ± 0.02 
F1=1.26 ± 0.05 
F2=1.06 ± 0.06 
F3=0.87 ± 0.08 
F4=0.46 ± 0.12 
In my study fibrosis stage, F2 ≥ will be considered 
positive for fibrosis. 
The results were then compared with a liver biopsy 
performed by the medicine department MU1 and 
histological staging analyzed by the pathology 
department of the same hospital. A liver biopsy 
specimen was obtained by a pathologist and blindly 
reviewed. The METAVIR staging system of the degree 
of fibrosis and cirrhosis was used in liver biopsy 
specimen interpretation by the pathology department. 
Fibrosis is staged from 0 to 4 according to METAVIR 
SYSTEM. 
            F0=No fibrosis 
            F1=portal fibrosis without septa 
            F2=portal fibrosis with few septa 
             F3=portal fibrosis with numerous septa 
without cirrhosis 
            F4=cirrhosis 
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In my study fibrosis is considered from stage FI to F4. 
Data Analysis: Data was entered on computer 




A total of seventy-five (n=75) patients age between 18-
50 years having clinical besides laboratory evidence of 
chronic liver disease and positive PCR of hepatitis B 
were enrolled. Subjects with a history of 
splenomegaly, interferon therapy, and having 
esophageal varices were excluded from the study. 
Informed consent was taken from each patient. 
Doppler ultrasound of the hepatic vein was performed 
of every patient and HVRI was measured.  
Results of the Doppler ultrasound were compared 
with liver biopsy findings. 57.3% (n=43) males having 
a mean age of 38.6 years ± 8.2 SD and 42.7% (n=32) 
were females having a mean age of 37.1 years ± 8.7 SD. 
There were 54.7% (n=41) of patients who were 
between age 18-40 years and 45.3% (n=34) were 
greater than 40 years of age. Demographic results are 
shown in Tables 1 and 2. 
 
Table 1: Gender and age distribution of subjects  
Gender Number (%) Mean Age ± SD (years) 
Male 43 (57.3%) 38.6 ± 8.2 
Females 32 (42.7%) 37.1 ± 8.7 
Total 75 (100%) 38.0 ± 8.4 
 





Frequency Percent Cumulative 
Percent 
18-40 41 54.7 54.7 
>40 34 45.3 100 
Total 75 100.0  
 
Results of ultrasound showed 48.0% (n=36) positive 
and 52.0% (n=39) negative as per our operational 
definition (Table 3). Liver biopsy results showed that 
60% (n=45) of patients were positive and 40% (n=30) 
were negatives as per criteria defined in our 
operational definition (Table 4). Cross-tabulation of 
ultrasound (HVRI) and liver biopsy results are shown 
in (Table 5). 
Table 3:  Ultrasound (HVRI) results 
 Frequency Percent Cumulative 
Percent 
Positive 36 48 48 
Negative 39 52 100 
Total 75 100  
 
Table 4:  Liver biopsy 
 Frequency Percent Cumulative 
Percent 
Positive 45 60 60 
Negative 30 40 100 
Total 75 100.0  
 
Table 5:  Cross-tabulation of ultrasound (HVRI) and 
liver biopsy results 
 LIVER BIOPSY FINDINGS  



















Liver biopsy remains the typical procedure to 
diagnose the level of fibrosis in chronic liver disease 
but it is an invasive procedure and may lead to serious 
complications if not performed properly.19 The hepatic 
venous resistive index has been investigated using 
color Doppler ultrasonography as a non-invasive 
technique in CLD, especially in subjects having portal 
hypertension, portal vein thrombosis, and also in 
Budd-chiari-syndrome. Doppler examination protocols 
however differ because no standard technique has 
been established so far.19 
Liver surface assessment using ultrasound showed 
reasonable diagnostic precision in studies that 
confirmed good research practice. Further procedures 
however have proven variable or mild to moderate 
diagnostic accuracy. In our study, we have tried 
hepatic venous resistive index measurements through 
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color Doppler analysis for noninvasive detection of 
fibrosis. If diagnostic accuracy of this technique could 
be proved, this would be very beneficial for the 
patients as it is a readily available, non-invasive, and 
cost-effective technique for the diagnosis of liver 
fibrosis and it can help the treating physicians in 
timely management of these patients.  
Seventy-five (n=75) patients with hepatitis B aged 
between I 8-50 years were enrolled. Data showed 
Sensitivity, specificity, PPV, NPV, and accuracy were 
found to be 77.7%, 96.7%, 97.2%, 74.3%, and 85.3% 
respectively, which is the same as compared to a study 
done by Lutz HH et al. who compared Doppler 
ultrasound of hepatic veins with liver histology and 
transient elastography (TE). Iwao T, et al also 
concluded that in advanced liver fibrosis, phasicity of 
hepatic veins dampens, and ultimately it may lead to 
the reduced caliber and non-visualization of hepatic 
veins. 
In a study conducted by Abbattis T, et al on contrast-
enhanced ultrasound assessment of hepatic veins he 
concluded that Qontrast-calculated TTP was 
considerably shorter in cirrhotic cases (vs non-
cirrhotics and healthy subjects) (71.0 + 11.3s vs 82.4 + 
15.6s, 86.3 + 20.3s, P<0.05) when the sample was 
placed in the main hepatic vein.  
MA Azizah et al also conducted a study to see the 
association of hepatic venous waveform with liver 
cirrhosis and their study also demonstrated that HV 
spectral waveform was changed in cirrhotic subjects. 
11 of 56 cirrhotic showed dampening of hepatic vein 
Doppler spectral waveform. They noticed the 
incidence of flattening of HV waveforms correlates 
with the severity of cirrhosis and there are chances of 
observing venous outflow hindrance in patients with 
advanced cirrhosis.  
They concluded that this increased stiffness of hepatic 
parenchyma leads to loss of plasticity in hepatic veins 
due to impairment of hepatic venous compliance and 
this incidence of the flattened waveform was 
associated with the severity of cirrhosis. Venous 
waveform dampening is more frequently seen in 
cirrhosis.20 Similar results are seen in our study. 
Figures 1 and 2 showing the dampening of venous 
waveform with the advancement in the stage of 
fibrosis. 
 




Figure 2: Monophasic waveform in advanced 
cirrhosis 
 
Reports published in the literature to date and the 
results of this study showed its encouraging potential 




Hepatic vein resistive index is a reliable noninvasive 
method in the detection of patients with liver fibrosis 
and can detect liver fibrosis in patients of CLD with 
overall sensitivity, specificity, PPV, NPV, and accuracy 
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